admin

Check out the companies making headlines before the bell: Johnson & Johnson – J&J shares rose roughly 1% in the premarket after the company beat quarterly forecasts and raised its earnings outlook amid strong sales of drugs and medical devices. J&J reported adjusted quarterly earnings of $2.48 per share, beating the $2.27 consensus estimate, with revenue
0 Comments
Defensive stocks, which typically have low market risk, are getting increased attention. And these types of shares are popular because they can help protect portfolios from rapid market declines or wild swings in returns. Today, I’ll introduce seven defensive stocks to buy for the earnings season. Despite stomach-churning volatility, especially in the early days of the
0 Comments
The historical market risk premium is the difference between what an investor expects to make as a return on an equity portfolio and the risk-free rate of return. Over the last century, the historical market risk premium has ranged (depending on the approach of the analyst) from 3% to 12%. Key Takeaways Historical market risk
0 Comments
Zomedica (NYSEAMERICAN:ZOM) is the “meme stock” that just can’t take off. Despite constant prodding from Reddit and even some positive opinions from InvestorPlace, this pet health company remains in the penny stock dungeon. In fact, ZOM stock shares haven’t traded above $1 since April. Source: didesign021 / Shutterstock.com Fortunately, though, help is on the way
0 Comments
After suffering from the pandemic last year, the energy sector is by far the best-performing sector of the stock market this year making royalty trusts worth another look. Thanks to the massive rollout of vaccines and the deep production cuts of OPEC and Russia, the price of oil has rallied to a 3-year high while
0 Comments
The pandemic gave all retail companies a giant boost. So much so that they not only quickly recovered from the Covid-19 crash but eclipsed it. Jumia (NYSE:JMIA) stock rallied as much as 3,100% off the March 2020 bottom. Losing a few ticks is more than necessary. Nothing rallies to the moon without rest, therefore the
0 Comments
Mind Medicine (NASDAQ:MNMD) is a clinical-stage biotech company that is developing multiple psychedelic treatments for various mental health conditions. With numerous therapy programs in development, the goal is to effectively leverage the latest innovations to develop medicines that have never been commercialized previously. However, with no revenues, mounting losses, and an array of business risks,
0 Comments
Check out the companies making headlines before the bell: Travelers – The insurance company earned $3.45 per share for its second quarter, easily beating the consensus estimate of $2.39. Revenue also topped forecasts, with Travelers benefiting from higher premiums, improved investment returns and lower catastrophe losses.  Nasdaq – Nasdaq shares rose 1% in the premarket after
0 Comments
Growth has clearly been the winning investment strategy over the past decade. Buying shares of well-managed businesses in industries with above-average growth has proven capable of superior portfolio performance. Therefore today, we’ll discuss seven growth stocks that could be appropriate for a range of InvestorPlace.com readers. Most growth stock have high valuation metrics, such above
0 Comments
Editor’s note: Below you’ll find the week 47 release of the NYC Recovery Index, originally published July 16, 2021. Visit the NYC Recovery index homepage for the latest data. New York City’s economic recovery made some progress as of July 3, though not enough to raise its overall score, which settled at 74. A sustained
0 Comments
Income investors are always searching for high yields, which are hard to find with today’s historically low interest rates and record-high stock prices. But investors should not sacrifice dividend safety in favor of higher yields. This is why high-quality dividend stocks like the Dividend Aristocrats are so valuable. The Dividend Aristocrats are a select group
0 Comments
General Electric (NYSE:GE) stock is down on its luck this summer, but it’s far from suffering. Year-to-date it’s up 16% and up 75% in a year. That’s 40% more than Apple (NASDAQ:AAPL), to mention one leader. Source: Sundry Photography / Shutterstock.com Management, therefore, deserves a lot of credit. This comes after tremendous criticism going into
0 Comments
In any other circumstance, Opendoor Technologies (NASDAQ:OPEN) stock may have been a no-brainer investment. Source: PREMIO STOCK/Shutterstock.com As you probably know, owning real estate is the epitome of the American Dream — but the paperwork to seal the deal is a veritable nightmare. Opendoor’s digitalization of the buying and selling process is the answer we’ve
0 Comments
The last time I wrote about the Israeli 3D printer Nano Dimension (NASDAQ:NNDM) was in early April. I was intrigued about the company because two of Ark Invest’s ETFs owned NNDM stock.  Source: Spyro the Dragon / Shutterstock.com Fast forward to mid-July. Ark Invest Chief Executive Officer and portfolio manager Cathie Wood has added to
0 Comments
Like almost everything else in life, your response to money is largely dictated by your personality. But have you given much thought to how you behave in regard to your finances and how that behavior affects your bottom line? Understanding your money personality is the first step and will help you shape your approach to
0 Comments